Conditional ligands for Asian HLA variants facilitate the definition of CD8+T‐cell responses in acute and chronic viral diseases
Open Access
- 26 December 2012
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 43 (4) , 1109-1120
- https://doi.org/10.1002/eji.201243088
Abstract
Conditional ligands have enabled the high‐throughput production of human leukocyte antigen (HLA) libraries that present defined peptides. Immunomonitoring platforms typically concentrate on restriction elements associated with European ancestry, and such tools are scarce for Asian HLA variants. We report 30 novel irradiation‐sensitive ligands, specifically targeting South East Asian populations, which provide 93, 63, and 79% coverage for HLA‐A, ‐B, and ‐C, respectively. Unique ligands for all 16 HLA types were constructed to provide the desired soluble HLA product in sufficient yield. Peptide exchange was accomplished for all variants as demonstrated by an ELISA‐based MHC stability assay. HLA tetramers with redirected specificity could detect antigen‐specific CD8+ T‐cell responses against human cytomegalovirus, hepatitis B (HBV), dengue virus (DENV), and Epstein‐Barr virus (EBV) infections. The potential of this population‐centric HLA library was demonstrated with the characterization of seven novel T‐cell epitopes from severe acute respiratory syndrome coronavirus, HBV, and DENV. Posthoc analysis revealed that the majority of responses would be more readily identified by our unbiased discovery approach than through the application of state‐of‐the‐art epitope prediction. This flow cytometry‐based technology therefore holds considerable promise for monitoring clinically relevant antigen‐specific T‐cell responses in populations of distinct ethnicity.Keywords
This publication has 40 references indexed in Scilit:
- Toward more accurate pan-specific MHC-peptide binding prediction: a review of current methods and toolsBriefings in Bioinformatics, 2011
- HLA class I supertypes: a revised and updated classificationBMC Immunology, 2008
- NetMHCpan, a Method for Quantitative Predictions of Peptide Binding to Any HLA-A and -B Locus Protein of Known SequencePLOS ONE, 2007
- Evidence of Viral Adaptation to HLA Class I-Restricted Immune Pressure in Chronic Hepatitis C Virus InfectionJournal of Virology, 2006
- Cancer Regression in Patients After Transfer of Genetically Engineered LymphocytesScience, 2006
- Design and use of conditional MHC class I ligandsNature Medicine, 2006
- Concomitant Administration of Interleukin-2 During Therapeutic Vaccinations Against Cancer: The Good, the Bad, or the Evil?Journal of Clinical Oncology, 2005
- Evidence of HIV-1 Adaptation to HLA-Restricted Immune Responses at a Population LevelScience, 2002
- Phenotypic Analysis of Antigen-Specific T LymphocytesScience, 1996
- HLA-A11 Epitope Loss Isolates of Epstein-Barr Virus From a Highly A11 + PopulationScience, 1993